Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | EPHA2 |
| Upstream (Parents) |
|---|
| (<<) APH1B → EPHA2 |
| (<<) CBFA2T3 → EPHA2 |
| (<<) GYS1 → EPHA2 |
| (<<) HDAC2 → EPHA2 |
| (<<) IL6 → EPHA2 |
| (<<) KCNJ2 → EPHA2 |
| (<<) KLF2 → EPHA2 |
| (<<) MAP3K14 → EPHA2 |
| (<<) MPP1 → EPHA2 |
| (<<) NFKBIE → EPHA2 |
| (<<) PSORS1C2 → EPHA2 |
| (<<) RPS6KA3 → EPHA2 |
| (<<) UPP1 → EPHA2 |
| (<<) ZFP36 → EPHA2 |
| Downstream (Children) |
|---|
| EPHA2 → BCL2A1 (>>) |
| EPHA2 → CDR2 (>>) |
| EPHA2 → CLCF1 (>>) |
| EPHA2 → EPHB3 (>>) |
| EPHA2 → FER1L4 (>>) |
| EPHA2 → GNAL (>>) |
| EPHA2 → JAG1 (>>) |
| EPHA2 → MAP3K2 (>>) |
| EPHA2 → PLD1 (>>) |
| EPHA2 → SOS1 (>>) |
